What is 'Society Sponsorship Navigator'?

It is a matching platform that connects medical societies and research groups nationwide with potential sponsors, including those outside the medical industry. The aim is to stabilize funding for medical societies and support research development.

How many medical societies are listed on 'Society Sponsorship Navigator'?

Over 6,000 societies are listed, with approximately 3,800 of them being future events. The listings are updated regularly.

What are the benefits for non-medical industry companies to sponsor medical societies?

They can directly approach the highly purchasing and specialized physician and healthcare professional audience.

Are there any costs associated with using the service?

Search, membership registration, and intermediary services are free of charge initially. However, a separate fee is charged upon successful agreement.

Why is such a platform necessary?

Due to the strengthening of transparency guidelines and restructuring in the industry, traditional pharmaceutical and medical device companies have reduced their sponsorship. This has put the operation of medical societies and support for young researchers at risk.

AI News NQ Analysis

Launch of 'Gakkai Kyosan Navi': A Sponsorship Matching Platform Connecting Over 6,000 Medical Societies with Cross-Industry Companies

NQ Score 90/100

N1 Content Completeness 10

Key facts

Launch of 'Gakkai Kyosan Navi': A Sponsorship Matching Platform Connecting Over 6,000 Medical Societies with Cross-Industry Companies
株式会社オージャスト officially launched 'Gakkai Kyosan Navi' on May 21, 2026, a platform connecting medical societies with potential sponsors. It aims to revitalize medical research funding by facilitating cross-industry sponsorship, countering the decline in traditional pharmaceutical sponsorships.
Source: PR TIMES
Date: Mon May 25 2026 18:00:02 GMT+0900 (Japan Standard Time)

Direct answer

株式会社オージャスト officially launched 'Gakkai Kyosan Navi' on May 21, 2026, a platform connecting medical societies with potential sponsors. It aims to revitalize medical research funding by facilitating cross-industry sponsorship, countering the decline in traditional pharmaceutical sponsorships.

Citation: Launch of 'Gakkai Kyosan Navi': A Sponsorship Matching Platform Connecting Over 6,000 Medical Societies with Cross-Industry Companies (Mon May 25 2026 18:00:02 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Mon May 25 2026 18:00:02 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

株式会社オージャスト officially launched 'Gakkai Kyosan Navi' on May 21, 2026, a platform connecting medical societies with potential sponsors. It aims to revitalize medical research funding by facilitating cross-industry sponsorship, countering the decline in traditional pharmaceutical sponsorships.

AI Analysis

Frequently Asked Questions

Q: What is 'Society Sponsorship Navigator'?: A: It is a matching platform that connects medical societies and research groups nationwide with potential sponsors, including those outside the medical industry. The aim is to stabilize funding for medical societies and support research development.
Q: How many medical societies are listed on 'Society Sponsorship Navigator'?: A: Over 6,000 societies are listed, with approximately 3,800 of them being future events. The listings are updated regularly.
Q: What are the benefits for non-medical industry companies to sponsor medical societies?: A: They can directly approach the highly purchasing and specialized physician and healthcare professional audience.
Q: Are there any costs associated with using the service?: A: Search, membership registration, and intermediary services are free of charge initially. However, a separate fee is charged upon successful agreement.
Q: Why is such a platform necessary?: A: Due to the strengthening of transparency guidelines and restructuring in the industry, traditional pharmaceutical and medical device companies have reduced their sponsorship. This has put the operation of medical societies and support for young researchers at risk.